Showing results (141-150 of 238) with videos related to

Sort By:
Pageof 24
Journal of Clinical Periodontology|May 15, 2001
Prevalence and risk indicators for destructive periodontal diseases in 3 urban American minority populationsR G Craig, R Boylan, J Yip, et al.
Journal of Hematology & Oncology|June 1, 2021
Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitorsEvangelos Terpos, Flora Zagouri, Michalis Liontos, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|December 29, 2025
Scaling up 3D Kernels with Bayesian Frequency Re-parameterization for Medical Image SegmentationHo Hin Lee, Quan Liu, Shunxing Bao, et al.
Plos One|December 11, 2012
Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccineRichard Stebbings, Michèle Février, Bo Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2011
An adjuvanted polyprotein HIV-1 vaccine induces polyfunctional cross-reactive CD4+ T cell responses in seronegative volunteersEva Van Braeckel, Patricia Bourguignon, Marguerite Koutsoukos, et al.
Cancers|March 6, 2021
Continuing Cancer Therapy through the Pandemic While Protecting Our Patients: Results of the Implementation of Preventive Strategies in a Referral Oncology UnitMichalis Liontos, Efstathios Kastritis, Christos Markellos, et al.
Osteoarthritis and Cartilage|April 22, 2006
An integrated analysis of five double-blind, randomized controlled trials evaluating the safety and efficacy of a hyaluronan product for intra-articular injection in osteoarthritis of the kneeV Strand, P G Conaghan, L S Lohmander, et al.
Cancers|July 14, 2023
Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian CancerAngeliki Andrikopoulou, Charalampos Theofanakis, Christos Markellos, et al.
Journal of Ovarian Research|November 2, 2021
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapyM Liontos, A Andrikopoulou, K Koutsoukos, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of ExperienceMichalis Liontos, Anna Svarna, Charalampos Theofanakis, et al.
Pageof 24